Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tariq Aziz

Showing results (341-350 of 349) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 349 results.
Acta Biochimica Polonica|November 8, 2023
Isolation, preparation and investigation of leaf extracts of Aloe barbadensis for its remedial effects on tumor necrosis factor alpha (TNF-α) and interleukin (IL-6) by in vivo and in silico approaches in experimental ratsIram Khurshaid, Sobia Ilyas, Nureen Zahra, et al.
Polymers|August 12, 2022
A Review on the Modification of Cellulose and Its ApplicationsTariq Aziz, Arshad Farid, Fazal Haq, et al.
BMC Plant Biology|April 13, 2026
Effect of alone & combined application of benzylaminopurine and gibberellic acid on in-vitro germination and growth rate of broccoliTariq Aziz Khan, Muntaha Munir, Qasim Ali, et al.
Journal of Ethnopharmacology|August 16, 2025
Anti-breast cancer effects of Pterocarpus soyauxii Taub aqueous extract and its compounds by integrating ADMET, network pharmacology, molecular docking, dynamic simulation, CLC-Pred and pdCSM-Cancer/PPI approaches, and in vitro validationOwona Pascal Emmanuel, Mengue Ngadena Yolande Sandrine, Bilanda Danielle Claude, et al.
The Lancet. Oncology|April 12, 2024
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trialAna Oaknin, Kathleen Moore, Tim Meyer, et al.
Scientific Reports|April 4, 2026
Urban forests baseline and ecosystem benefits of a tropical metropolis: case of Dhaka, BangladeshSahadeb Chandra Majumder, Md Shams Uddin, Md Akhter Hossain, et al.
Journal of Family Medicine and Primary Care|July 17, 2020
A Statement of Solidarity on COVID-19 Pandemic 2020 by the South Asian Family PhysiciansRaman Kumar, Shehla Naseem, Jayantha Jayatissa, et al.
JAMA Oncology|April 6, 2023
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical TrialKevin J Harrington, Robert L Ferris, Maura Gillison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2022
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651Robert I Haddad, Kevin Harrington, Makoto Tahara, et al.
Pageof 35

Showing results (341-350 of 349) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 349 results.
Acta Biochimica Polonica|November 8, 2023
Isolation, preparation and investigation of leaf extracts of Aloe barbadensis for its remedial effects on tumor necrosis factor alpha (TNF-α) and interleukin (IL-6) by in vivo and in silico approaches in experimental ratsIram Khurshaid, Sobia Ilyas, Nureen Zahra, et al.
Polymers|August 12, 2022
A Review on the Modification of Cellulose and Its ApplicationsTariq Aziz, Arshad Farid, Fazal Haq, et al.
BMC Plant Biology|April 13, 2026
Effect of alone & combined application of benzylaminopurine and gibberellic acid on in-vitro germination and growth rate of broccoliTariq Aziz Khan, Muntaha Munir, Qasim Ali, et al.
Journal of Ethnopharmacology|August 16, 2025
Anti-breast cancer effects of Pterocarpus soyauxii Taub aqueous extract and its compounds by integrating ADMET, network pharmacology, molecular docking, dynamic simulation, CLC-Pred and pdCSM-Cancer/PPI approaches, and in vitro validationOwona Pascal Emmanuel, Mengue Ngadena Yolande Sandrine, Bilanda Danielle Claude, et al.
The Lancet. Oncology|April 12, 2024
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trialAna Oaknin, Kathleen Moore, Tim Meyer, et al.
Scientific Reports|April 4, 2026
Urban forests baseline and ecosystem benefits of a tropical metropolis: case of Dhaka, BangladeshSahadeb Chandra Majumder, Md Shams Uddin, Md Akhter Hossain, et al.
Journal of Family Medicine and Primary Care|July 17, 2020
A Statement of Solidarity on COVID-19 Pandemic 2020 by the South Asian Family PhysiciansRaman Kumar, Shehla Naseem, Jayantha Jayatissa, et al.
JAMA Oncology|April 6, 2023
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical TrialKevin J Harrington, Robert L Ferris, Maura Gillison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2022
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651Robert I Haddad, Kevin Harrington, Makoto Tahara, et al.
Pageof 35